Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today marks the launch of a new Oxford-wide initiative – the Oxford Centre for Haematology (OCH).

This virtual Centre aims to promote integration between academic and clinical haematology programmes in the University and Oxford University Hospitals NHS Foundation Trust and thereby capitalise on scientific opportunities to transform our understanding of haematopoiesis and blood diseases, with the goal of radically improving patient care.

The OCH will be led by Prof Paresh Vyas, a member of the MRC Molecular Haematology Unit based at the MRC WIMM, and several of the centre’s members are based at our Institute.

OCH builds on over 40 years of haematology research excellence in Oxford. From the pioneering work on globins led by our founder Professor Sir David Weatherall, Prof John Clegg and Prof Doug Higgs, through to our current position of driving the largest blood cancer clinical trials program in the UK, Oxford is truly a powerhouse of haematology research. OCH will build on, and enhance, our understanding of blood cancers, ageing of the haematopoietic system and the links with inflammation and immunity. The Centre will also raise new funding for research, trials and implementation into clinical practice, alongside training the next generation of scientists and healthcare professionalsand encouraging partnerships.

Establishing the Centre has been made possible thanks to funding from the NIHR Oxford Biomedical Research Centre and will be hosted by RDM, embedded within the Nuffield Division of Clinical Laboratory Sciences.

More information can be found here and all are invited to attend the OCH Inaugural Symposium on the 26 March.

Please direct any questions about OCH to Julie Stevens,whose desk is based in the WIMM’s Administration Office.

Similar stories

Project funding for personalised childhood cancer treatments

Funding from the Azaylia Foundation will support the Scientific Advances for Infant Leukaemia (SAIL) programme.

MRC National Mouse Genetics Network Research Clusters Announced

Claus Nerlov and Steve Twigg from the MRC WIMM join the new national network for disease modelling.

RDM announces new Principal Investigators

Dr Stephen Twigg has been announced as one of eight new Principal Investigators by the Radcliffe Department of Medicine.

Patient priorities guide Oxford Myeloma research

Medical staff in Oxford are partnering closely with Myeloma patients to help set priorities for future research.

From ‘Ew, gross!’ to ‘Wow!’: Scientists bring immunology to the classroom

For British Science Week, members of the MRC WIMM visited a local Oxfordshire primary school for an interactive science day – one of the first of its kind since the start of the pandemic.